Hypertriglyceridemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With ... - Nasdaq



Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With ... 
Nasdaq
The oral presentation, "Increased Cardiovascular Risk in Patients with Statin-Controlled LDL Cholesterol and Residual Hypertriglyceridemia," was done in collaboration with Gregory A. Nichols, PhD, from Kaiser Permanente Center for Health Research, and ...

and more » 


Hypertriglyceridemia Market Research Report 2017 to 2025 - Research of Market



Hypertriglyceridemia Market Research Report 2017 to 2025 
Research of Market
Hypertriglyceridemia-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Hypertriglyceridemia. The report provides a complete understanding of the pipeline activities ...

and more » 


Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China ... - Marketwired (press release)



Stock News Union
 
Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China ... 
Marketwired (press release)
Acasti's prescription drug candidate, CaPre, is a highly purified omega-3 phospholipid concentrate derived from krill oil and is being developed to treat severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of ...
Acasti Pharma Inc (NASDAQ:ACST) Booms on Possible Deal Stock News Union (blog)
Possible $125 Million Deal for Acasti's CaPre Gets Market Buzzing Baystreet.ca
What Will Happen to Acasti Pharma Inc (ACST) Next? The Stock Just Increased A Lot Weekly Register
Modern Readers 
all 26 news articles » 


Hot Stock of the Day: Bitauto Holdings Limited (NYSE: BITA) - Alpha Beta Stock



Hot Stock of the Day: Bitauto Holdings Limited (NYSE: BITA) 
Alpha Beta Stock
With the high prevalence of hypertriglyceridemia in Asia, this potential partnership presents a noteworthyopportunity for Acasti and CaPre. If a definitive agreement is reached and signed, the term sheet contemplates that Acasti would receive an ...

and more » 


Technicals in Focus: Meritor Inc (NYSE: MTOR) - Alpha Beta Stock



Technicals in Focus: Meritor Inc (NYSE: MTOR) 
Alpha Beta Stock
With the high prevalence of hypertriglyceridemia in Asia, this potential partnership presents a noteworthyopportunity for Acasti and CaPre. If a definitive agreement is reached and signed, the term sheet contemplates that Acasti would receive an ...

and more » 


Hot Stock of the Day: Kimco Realty Corporation (NYSE: KIM) - Alpha Beta Stock



Hot Stock of the Day: Kimco Realty Corporation (NYSE: KIM) 
Alpha Beta Stock
With the high prevalence of hypertriglyceridemia in Asia, this potential partnership presents a noteworthyopportunity for Acasti and CaPre. If a definitive agreement is reached and signed, the term sheet contemplates that Acasti would receive an ...

 


Notable Indicators to Study Before Making Any Investment Decision: Gold Fields Limited (NYSE: GFI) - Alpha Beta Stock



Notable Indicators to Study Before Making Any Investment Decision: Gold Fields Limited (NYSE: GFI) 
Alpha Beta Stock
With the high prevalence of hypertriglyceridemia in Asia, this potential partnership presents a noteworthyopportunity for Acasti and CaPre. If a definitive agreement is reached and signed, the term sheet contemplates that Acasti would receive an ...

and more » 


Zydus Announces Regulatory Approval of Lipaglyn? (Saroglitazar Magnesium) in Mexico - PR Newswire (press release)



Hindu Business Line
 
Zydus Announces Regulatory Approval of Lipaglyn? (Saroglitazar Magnesium) in Mexico 
PR Newswire (press release)
"Saroglitazar is an important scientific and medical breakthrough in our effort to develop medicines for patients suffering from hypertriglyceridemia and diabetic dyslipidemia," said Mr. Pankaj Patel, Chairman, Zydus Group, and added, "This approval of ...
Zydus gets regulatory nod to market Lipaglyn in Mexico Hindu Business Line
Cadila Healthcare gets Mexico regulator approval for Lipaglyn Indiainfoline
Novel Indian discovered dyslipidemia drug approved in Mexico The Pharma Letter
Ultra News 
all 7 news articles » 


Akcea and Ionis Report Positive Phase 1/2a Data with AKCEA-APOCIII-LRxAkcea expects to initiate Phase 2b in ... - Markets Insider



Akcea and Ionis Report Positive Phase 1/2a Data with AKCEA-APOCIII-LRxAkcea expects to initiate Phase 2b in ... 
Markets Insider
... for AKCEA-APO(a)-LRx in patients with high lipoprotein(a), or Lp(a), with established cardiovascular disease and to initiate a Phase 2 dose-ranging study for AKCEA-APOCIII-LRx in patients with hypertriglyceridemia and established cardiovascular ...

and more » 


Health Care Sector Update for 11/20/2017: SMMT,ACST,ACST.V ... - Nasdaq



Health Care Sector Update for 11/20/2017: SMMT,ACST,ACST.V ... 
Nasdaq
Health care stocks turned lower Monday afternoon, with the NYSE Health Care Index falling over 0.2% while shares of health care companies in the S&P 500 ...

and more »